Biodexa Pharmaceuticals (BDRX) Other Non Operating Income (2015 - 2020)

Biodexa Pharmaceuticals (BDRX) reported Other Non Operating Income of $88149.6 for Q3 2020, down 98.22% sequentially from $4.9 million in Q4 2018.

Biodexa Pharmaceuticals (BDRX) Other Non Operating Income (2015 - 2020) Analysis & Trends

Biodexa Pharmaceuticals (BDRX) has 3 years of Other Non Operating Income data on file, last reported at $88149.6 in Q3 2020.

For the quarter ending Q3 2020, Other Non Operating Income changed N/A year-over-year to $88149.6; the trailing twelve-month figure through Dec 2018 stood at $4.9 million (changed N/A YoY), and the FY2025 full-year result was -$171406.3, down 3438.65% from the prior year.
Other Non Operating Income retreated to $88149.6 in Q3 2020, from $4.9 million in the prior quarter.
In the past five years, Other Non Operating Income ranged from a high of $4.9 million in Q4 2018 to a low of $88149.6 in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Biodexa Pharmaceuticals	18.43 Bn	18.43 Bn	-

Download Data